Pharmacovigilance and clinical trials academic journals is the facilitates communication between members of educational discipline . Pharmacovigilance and clinical trials academic journal publishes review articles. It is briefly report on the new research within the field of drug efficacy, prescribing errors, adverse drug events & global health systems. This Pharmacovigilance academic journal is peer reviewed by editorial board members of the journal. They are available in print format as well as electronic format. Journals dedicated to rapid publication of basic and clinical research findings in assessment of the risks/benefits profiles of pharmaceutical intervention safety, side effects and adverse effects also as medications toxicity. Clinical trials pharmacovigilance deals with the writing and distribution of safety aggregate reports like Periodic safety update reports, drug safety reports, and clinical trials from Phase I to Phase IV. ..
Short Communication: Pharmaceutical Regulatory Affairs: Open Access
Short Communication: Pharmaceutical Regulatory Affairs: Open Access
Review Article: Pharmaceutical Regulatory Affairs: Open Access
Review Article: Pharmaceutical Regulatory Affairs: Open Access
Mini Review: Pharmaceutical Regulatory Affairs: Open Access
Mini Review: Pharmaceutical Regulatory Affairs: Open Access
Research Article: Pharmaceutical Regulatory Affairs: Open Access
Research Article: Pharmaceutical Regulatory Affairs: Open Access
Posters & Accepted Abstracts: Pharmacoeconomics: Open Access
Posters & Accepted Abstracts: Pharmacoeconomics: Open Access
Scientific Tracks Abstracts: Journal of Bioanalysis & Biomedicine
Scientific Tracks Abstracts: Journal of Bioanalysis & Biomedicine
Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Keynote: Journal of Bioanalysis & Biomedicine
Keynote: Journal of Bioanalysis & Biomedicine
Scientific Tracks Abstracts: Journal of Bioanalysis & Biomedicine
Scientific Tracks Abstracts: Journal of Bioanalysis & Biomedicine
Pharmaceutical Regulatory Affairs: Open Access received 533 citations as per Google Scholar report